McKesson

McKesson (NYSE: MCK) is a diversified healthcare services company that distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products, mainly in North America. The company also develops and implements software that facilitates data integration within the health industry. Founded in 1833, it is one of the largest distributors of wholesale pharmaceutical drugs in the US and was ranked ninth in the Fortune 500 list of the largest companies in the US in 2023. McKesson generated USD 276 billion in revenue for FY2023. 

McKesson has four reportable segments: US Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. US Pharmaceutical, the largest segment, with ~87% of group revenue, focuses on distributing branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products in the US. The Prescription Technology Solutions segment covers medication access, affordability, and adherence solutions for patients, while the Medical-Surgical Solutions segment comprises medical-surgical supply distribution and logistics services to healthcare providers. The International segment comprises all retail and wholesale distribution operations and other services in Europe and Canada. 

The US accounted for ~93% of McKesson’s FY2023 top line and is the single largest geography for the company. Canada and the remaining Europe operations round up the remainder.

In November 2023, McKesson raised its FY 2024 revenue growth target marginally to 8%–12% YoY (previously 7%–12%) and adjusted diluted EPS for FY 2024 to USD 26.80–27.40 (previously USD 26.55–27.35).